Company Filing History:
Years Active: 2020
Title: Long Rong - Innovator in Cancer Treatment
Introduction
Long Rong is a notable inventor based in Beijing, China. He has made significant contributions to the field of chemical and pharmaceutical technology. His work primarily focuses on developing innovative solutions for cancer treatment.
Latest Patents
Long Rong holds a patent for a "STAT3 and ERK signal pathway inhibitor comprising mogrosides and analogs thereof." This invention relates to a chemical and pharmaceutical technology that provides a method for inhibiting the phosphorylation of the transcription factor STAT3 and the phosphorylation of ERK. The inhibitor mainly consists of mogrosides and/or their analogs. The preparation method for these compounds is characterized by its simplicity, strong operability, and high purity of products. This invention has promising applications in the preparation of drugs for treating tumors, effectively inhibiting the proliferation of cancer cells and promoting their apoptosis.
Career Highlights
Long Rong is affiliated with the Beijing University of Agriculture, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Some of Long Rong's notable coworkers include Can Liu and Lanqing Ma, who contribute to his research endeavors.
Conclusion
Long Rong's innovative work in developing STAT3 and ERK signal pathway inhibitors represents a significant advancement in cancer treatment. His contributions to pharmaceutical technology are paving the way for more effective therapies against cancer.